SUMMARY A patient with severe variant angina that was refractory to conventional treatment became symptom free when she was treated with benzhexol (trihexyphenidyl hydrochloride), a cholinergic blocking agent used in the management of Parkinson's disease. There was a brief psychotic reaction when a large dose was taken and some memory impairment on the maintenance dose. Benzhexol should be used with caution but may prove io be an additional therapeutic agent in the management of severe variant angina. At initial examination she had a heart rate of 90 beats per minute in sinus rhythm and a blood pressure of 200/100 mm Hg. An apical fourth heart sound and multiple mid-systolic clicks were also noted. The electrocardiogram showed incomplete right bundle branch block and counterclockwise rotation of the heart about its longitudinal axis. A radiograph of the chest was unremarkable apart from some old right basal lung scarring. M mode echocardiography showed no abnormality and Holter monitoring showed asymptomatic periods of T wave inversion associated with sinus tachycardia. Treadmill exercise electrocardiography was terminated by faintness at five minutes of the Bruce protocol. Nonspecific repolarisation changes only were seen. Routine haematology and biochemical assessment showed no abnormality. The atenolol that she had been receiving was replaced by nifedepine which at > 30 mg/day seemed to worsen symptoms whereas 5 mg three times a day was beneficial. Beta (Fig. 2) .. Similar group.bmj.com on August 15, 2017 -Published by http://heart.bmj.com/ Downloaded from reduced the dose of benzhexol by 2 mg every two days. When benzhexol was stopped completely the patient reported attacks of angina both at rest and on exercise which were associated with vomiting. She asked to restart the drug and was instructed to increase the dose by 2 mg every two days but she misunderstood these instructions and took the full dose of 4 mg four times a day. This precipitated a brief psychotic reaction with excitability and paranoia which resolved when the dose was reduced. Apart from the attacks of pain that she experienced during the period of withdrawal, the patient has had only four episodes of angina in the nine months since treatment with benzhexol was started, and two of these were associated with emotional upsets. She reports increased feelings of wellbeing and impairment of memory on the full dose-both are known side effects of benzhexol. She continues to take 4 mg of benzhexol three times a day.
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Discussion
The use of benzhexol is a novel approach to treating variant angina. Yasue reported that atropine (a parasympathetic blocking agent) at a dose of 1 -2 to 2-0 mg at night suppressed attacks of pain in about 80% of cases.7 He nevertheless commented that atropine was not likely to have any advantages over the newly developed calcium antagonists. Our patient responded well to benzhexol, after treatment with a calcium antagonist had been unsuccessful. The mechanisms involved in variant angina when the coronary arteries appear to be nearly normal by angiography and the condition is refractory to calcium channel blocking agents are unknown. In vitro the contractile response of human coronary arteries to various physiological agents, including acetylcholine, is biphasic.8 The response to acetylcholine is dependent on a fast phase of contraction mediated 
